Some rapid antigen Covid tests may not detect Omicron, says Fauci

Some of the rapid at-home Covid-19 tests available in the US may not accurately pick up the new super mutant Omicron variant, the country's top infectious disease expert Anthony Fauci said.

Anthony Fauci
Anthony Fauci
IANS Washington
3 min read Last Updated : Dec 17 2021 | 1:51 PM IST

Some of the rapid at-home Covid-19 tests available in the US may not accurately pick up the new super mutant Omicron variant, the country's top infectious disease expert Anthony Fauci said.

According to Fauci, the PCR tests, often considered the 'gold standard' for Covid testing, are accurate for detecting Omicron, the Daily Mail reported.

"We're getting preliminary information that not all of the diagnostic tests will be accurate with Omicron," Fauci said while addressing a virtual Chamber of Commerce Foundation audience on Thursday.

"Some, and many of the commonly used ones appear to pick up and detect Omicron quite well, we're hearing. We're in the process of doing large screening to determine which of these antigen point of care, rapid tests, still maintain their accuracy of diagnosis.

"But clearly there are some that don't. We're trying to find out those that don't reflect an accurate result. And if we do, make sure that those tests are not used to diagnose Omicron," he noted.

Rapid tests that are unable to detect the Omicron variant make for a worrying prospect, because of false results that could potentially lull people into a false sense of security.

Meanwhile, Fauci also noted that Omicron will become the dominant Covid-19 variant in the US within a few weeks, CNBC reported.

"It is the most transmissible virus of Covid that we had to deal with those far. It will soon become dominant here. That's one thing we know," Fauci was quoted as saying.

He urged people who are not yet inoculated against Covid and those who are eligible for a booster to receive their doses. He described the Omicron variant as "a threat in front of us right now".

"When you look at the pace of the infections now, things will get worse as we go into the depth of the winter," he said. "And with omicron breathing down our back, things could get really bad, particularly for the unvaccinated.

Though Omicron is more contagious than previous variants by spreading to at least 77 countries, it is not yet clear whether it causes more mild or severe Covid than the past strains.

President Joe Biden's top medical advisor said that those who are vaccinated and have taken their booster shots "will be relatively well protected at least against severe disease."

Fauci also said the US is experiencing a resurgence of the Delta variant, the report said.

"Delta is still a serious problem. I mean, we're looking over our shoulder at omicron, which will assume a dominant role very soon, I would imagine within a period of a few weeks as we go into January," Fauci explained.

"When you look at the Delta that we're dealing with right now, we're having an increase in every parameter, an increase in cases, an increase in hospitalisation and deaths are still at 1,100. So we are in for a difficult situation, particularly among those who are unvaccinated. They are very vulnerable."

--IANS

rvt/svn/ksk/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Dec 17 2021 | 1:51 PM IST

Next Story